Benutzerspezifische Werkzeuge

Publikationen 2016

  1. Baretton G, Dietel M, Gaiser T, Kirchner T, Kreipe HH, Quaas A, Röcken C, Rüschoff J, Tannapfel A, Lordick F, Al-Batran S, Hofheinz R, Lorenzen S, Moehler M, Thuss-Patience P (2016). HER2 testing in gastric cancer: results of a meeting of German experts. Pathologe 37:361-366
  2. Borkowetz A, Platzek I, Toma M, Renner T, Herout R, Baunacke M, Laniado M, Baretton G, Froehner M, Zastrow S, Wirth M (2016). Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy. BJU Int 118:213-220
  3. Dorn J, Yassouridis A, Walch A, Diamandis EP, Schmitt M, Kiechle M, Wang P, Drecoll E, Schmalfeldt B, Loessner D, Kotzsch M, Magdolen V (2016). Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome. Am J Cancer Res 6: 61-70
  4. Dornbusch J, Walter M, Gottschalk A, Obaje A, Junker K, Ohlmann CH, Meinhardt M, Zacharis A, Zastrow S, Schoffer O, Grimm MO, Klug SJ, Wirth MP, Fuessel S (2016). Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients. J Cancer Res Clin Oncol 142:1171-1182
  5. Dutta S, Roy S, Polavaram NS, Stanton MJ, Zhang H, Bhola T, Hönscheid P, Donohue TM, Band H, Batra SK, Muders MH, Datta K (2016). Neuropilin-2 regulates endosome maturation and EGFR trafficking to support cancer cell pathobiology. Cancer Res 76:418-428
  6. Dutta S, Roy S, Polavaram NS, Baretton GB, Muders MH, Batra S, Datta K (2016). NRP2 transcriptionally regulates its downstream effector WDFY1. Sci Rep 6:23588
  7. Froehner M, Heberling U, Zastrow S, Toma M, Wirth MP (2016). Growth of a level III vena cava tumor thrombus within 1 month. Urology 90:e1-e2
  8. Froehner M, Koch R, Heberling U, Novotny V, Oehlschlaeger S, Hübler M, Baretton GB, Hakenberg OW, Wirth MP (2016). Decreased overall and bladder cancer-specific mortality with adjuvant chemotherapy after radical cystectomy: multivariable competing risk analysis. Eur Urol 69:984-987
  9. Froehner M, Propping S, Koch R, Borkowetz A, Liebeheim D, Toma M, Baretton GB, Wirth MP (2016). Is the post-radical prostatectomy Gleason Score a valid predictor of mortality after neoadjuvant hormonal treatment? Urol Int 96:302-308
  10. Froehner M, Meinhardt M, Parmentier S, Hugo C, Wirth MP (2016). Renal sarcoidosis mimicking xanthogranulomatous pyelonephritis. Urology 97:e19-e20
  11. Galli R, Uckermann O, Temme A, Leipnitz E, Meinhardt M, Koch E, Schackert G, Steiner G, Kirsch M (2016). Assessing the efficacy of coherent anti-Stokes Raman scattering microscopy for the detection of infiltrating glioblastoma in fresh brain samples. J Biophotonics
  12. Gaumann, AK, Kiefer F, Alfer J, Lang SA, Geissler EK, Breier G (2016). Receptor tyrosine kinase inhibitors: Are they real tumor killers? Int J Cancer 138:540-554
  13. Gingras MC, Covington KR, Chang DK, Donehower LA, Gill AJ, Ittmann MM, Creighton CJ, Johns AL, Shinbrot E, Dewal N, Fisher WE, Australian Pancreatic Cancer Genome Initiative, Pilarsky C, Grützmann R, Overman MJ, Jamieson NB, Van Buren G, Drummond J, Walker K, Hampton OA, Xi L, Muzny DM, Doddapaneni H, Lee SL, Bellair M, Hu J, Han Y, Dinh HH, Dahdouli M, Samra JS, Bailey P, Waddell N, Pearson JV, Harliwong I, Wang H, Aust D, Oien KA, Hruban RH, Hodges SE, McElhany A, Saengboonmee C, Duthie FR, Grimmond SM, Biankin AV, Wheeler DA, Gibbs RA (2016) Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation. Cell Rep 14:907-919
  14. Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, Von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M, DKTK-ROG (2016). HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicenter retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother Oncol 121:364-373
  15. Linge A, Löck S, Gudziol V, Nowak A, Lohaus F, Von Neubeck C, Jütz M, Abdollahi A, Debus J, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Bayer C, Belka C, Pigorsch S, Combs SE, Welz S, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Baumann M, Krause M, DKTK-ROG (2016). Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG. Clin Cancer Res 22:2639-2649
  16. Lordick F, Al-Batran SE, Hofheinz RD, Lorenzen S, Thuss-Patience P, Baretton GB, Dietel M, Gaiser T, Kirchner T, Kreipe HH, Quaas A, Röcken C, Rüschoff J, Tannapfel A (2016). HER2 testing in gastric cancer - results of a German expert meeting. Z Gastroenterol 54:791-796
  17. Lutz MP, Zalcberg JR, Glynne-Jones R, Ruers T, Ducreux M, Arnold D, Aust D, Brown G, Bujko K, Cunningham C, Evrard S, Folprecht G, Gerard JP, Habr-Gama A, Haustermans K, Holm T, Kuhlmann KF, Lordick F, Mentha G, Moehler M, Nagtegaal ID, Pigazzi A, Puciarelli S, Roth A, Rutten H, Schmoll HJ, Sorbye H, Van Cutsem E, Weitz J, Otto F (2016) Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. Eur J Cancer 63:11-24
  18. Mierke F, Hempel S, Distler M, Aust DE, Saeger HD, Weitz J, Welsch T (2016). Impact of portal vein involvement from pancreatic cancer on metastatic pattern after surgical resection. Ann Surg Oncol 23:S730-S736
  19. Moehler M, Delic M, Goepfert K, Aust D, Grabsch HI, Halama N, Heinrich B, Julie C, Lordick F, Lutz MP, Mauer M, Alsina Maqueda M, Schild H, Schimanski CC, Wagner AD, Roth A, Ducreux M (2016). Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives. Eur J Cancer 59:160-170
  20. Möller FJ, Pemp D, Soukup ST, Wende K, Zhang X, Zierau O, Muders MH, Bosland MC, Kulling SE, Lehmann L, Vollmer G (2016) Soy isoflavone exposure through all life stages accelerates 17-estradiol- induced mammary tumor onset and growth, yet reduces tumor burden, in ACI rats. Arch Toxicol 90:1907-1916
  21. Niessner H, Schmitz J, Tabatabai G, Schmid AM, Calaminus C, Sinnberg T, Weide B, Eigentler TK, Garbe C, Schittek B, Quintanilla-Fend L, Bender B, Mai M, Praetorius C, Beissert S, Schackert G, Muders MH, Meinhardt M, Baretton GB, Dummer R, Flaherty K, Pichler BJ, Kulms D, Westphal D, Meier F (2016). PI3K pathway inhibition achieves potent antitumor activity in melanoma brain metastases in vitro and in vivo. Clin Cancer Res 22:5818-5828
  22. Peitzsch C, Cojoc M, Hein L, Kurth I, Mäbert K, Trautmann F, Klink B, Schröck E, Wirth MP, Krause M, Stakhovsky EA, Telegeev GD, Novotny V, Toma M, Muders M, Baretton GB, Frame FM, Maitland NJ, Baumann M, Dubrovska A (2016). An epigenetic reprogramming strategy to resensitize radioresistant prostate cancer cells. Cancer Res 76:2637-2651
  23. Pistorius S, Klink B, Pablik J, Rump A, Aust D, Garzarolli M, Schröck E, Schackert HK (2016). An unusual case of Cowden syndrome associated with ganglioneuromatous polyposis. Hered Cancer Clin Pract 14:11
  24. Plodeck V, Sommer U, Baretton GB, Aust DE, Laniado M, Hoffmann RT, Platzek I (2016) A rare case of pancreatic endometriosis in a postmenopausal woman and review of the literature. Acta Radiol Open 5:2058460116669385
  25. Rau TT, Atreya R, Aust D, Baretton G, Eck M, Erlenbach-Wünsch K, Hartmann A, Lugli A, Stöhr R, Vieth M, Wirsing AM, Zlobec I, Katzenberger T (2016). Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype-genotype correlation. J Pathol Clin Res 2:113-124
  26. Richter S, Klink B, Nacke B, De Cubas AA, Mangelis A, Rapizzi E, Meinhardt M, Skondra C, Mannelli M, Robledo M, Menschikowski M, Eisenhofer G (2016). Epigenetic mutation of the succinate Dehydrogenase C Promoter in a patient with two paragangliomas. J Clin Endocrinol Metab 101:359-363
  27. Schachschal G, Sehner S, Choschzick M, Aust D, Brandl L, Vieth M, Wegscheider K, Baretton GB, Kirchner T, Sauter G, Rösch T (2016). Impact of reassessment of colonic hyperplastic polyps by expert GI pathologists. Int J Colorectal Dis 31:675-683
  28. Schmidt J, Propping C, Siow WY, Lohse-Fischer A, Toma M, Baldauf-Twelker A, Hakenberg OW, Wirth MP, Fuessel S (2016) Diagnostic and prognostic value of bladder cancer-related transcript markers in urine. J Cancer Res Clin Oncol 142:401-414
  29. Scholz A, Harter PN, Cremer S, Yalcin BH, Gurnik S, Yamaji M, Di Tacchio M, Sommer K, Baumgarten P, Bähr O, Steinbach JP, Trojan J, Glas M, Herrlinger U, Krex D, Meinhardt M, Weyerbrock A, Timmer M, Goldbrunner R, Deckert M, Braun C, Schittenhelm J, Frueh JT, Ullrich E, Mittelbronn M, Plate KH, Reiss Y (2016)Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med 8:39-57
  30. Stiller M, Sucker A, Griewank K, Aust D, Baretton GB, Schadendorf D, Horn S (2016). Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA. Oncotarget 7:59115-59128
  31. Visser K, Zierau O, Macejová D, Goerl F, Muders M, Baretton GB, Vollmer G, Louw A (2016). The phytoestrogenic Cyclopia extract, SM6Met, increases median tumor free survival and reduces tumor mass and volume in chemically induced rat mammary gland carcinogenesis. J Steroid Biochem Mol Biol 163:129-135
  32. Volk A, Plodeck V, Toma M, Saeger HD, Pistorius S (2016). Treatment of tailgut cysts by extended distal rectal segmental resection with rectoanal anastomosis. Surg Today 47:457-462
  33. Wermke M, Schuster C, Nolte F, Al-Ali HK, Kiewe P, Schönefeldt C, Jakob C, Von Bonin M, Hentschel L, Klut IM, Ehninger G, Bornhäuser M, Baretton G, Germing U, Herbst R, Haase D, Hofmann WK, Platzbecker U (2016). Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS). Br J Haematol 175:917-924
  34. Werner K, Lademann F, Thepkaysone ML, Jahnke B, Aust DE, Kahlert C, Weber G, Weitz J, Grützmann R, Pilarsky C (2016) Simultaneous gene silencing of KRAS and anti- poptotic genes as a multitarget therapy. Oncotarget 7:3984–3992
  35. Zwingenberger S, Langanke R, Vater C, Lee G, Niederlohmann E, Sensenschmidt M, Jacobi A, Bernhardt R, Muders M, Rammelt S, Knaack S, Gelinsky M, Günther KP, Goodman SB, Stiehler M (2016). The effect of SDF-1on low dose BMP-2 mediated bone regeneration by release from heparinized mineralized collagen type I matrix scaffolds in a murine critical size bone defect model. J Biomed Mater Res A 104:2126-2134